OTLK
Outlook Therapeutics, Inc. · Healthcare
Director Faisal Ghiath Sukhtian bought $25K of Outlook Therapeutics, Inc.
Bought$25,200
$1.40Price
18,000Shares
+90%Stake
What OTLK did for a copier
- $1,000 copied at Thu, Dec 2 close, $27.60
- $964
- S&P 500, same days
- +2.0%
Measured over 30 trading days, to the Jan 14 close.
Faisal Ghiath Sukhtian's record
2 other buys on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, Dec 2. Filed Thu, Dec 2, 12:08 PM ET, during the session. Returns use the Dec 2 close and the Jan 14 close. Not investment advice.